Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Achim Goepferich

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Nanoscale Horizons|January 3, 2023
How clathrin-coated pits control nanoparticle avidity for cellsOliver Zimmer, Achim Goepferich
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 18, 2025
Control of biomedical nanoparticle distribution and drug release in vivo by complex particle design strategiesMelanie Bresinsky, Achim Goepferich
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 4, 2021
General sites of nanoparticle biodistribution as a novel opportunity for nanomedicineDaniel Fleischmann, Achim Goepferich
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2018
Nanoparticles Targeting Retinal and Choroidal Capillaries In VivoAlexandra Haunberger, Achim Goepferich
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 4, 2024
On the uncertainty of the correlation between nanoparticle avidity and biodistributionOliver Zimmer, Achim Goepferich
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2015
Nanoparticles for the treatment of ocular neovascularizationsRobert Hennig, Achim Goepferich
International Journal of Pharmaceutics|July 25, 2025
Dual cross-linked hydrogels as promising materials for drug deliveryCarsten Damm, Achim Goepferich
Biomaterials|October 3, 2006
Rational design of hydrogels for tissue engineering: impact of physical factors on cell behaviorFerdinand Brandl, Florian Sommer, Achim Goepferich
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 1, 2021
Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology - A new chance for causative therapy?Jonas Groner, Achim Goepferich, Miriam Breunig
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 16, 2014
Controlled release of therapeutic antibody formatsDaniel Schweizer, Tim Serno, Achim Goepferich
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Nanoscale Horizons|January 3, 2023
How clathrin-coated pits control nanoparticle avidity for cellsOliver Zimmer, Achim Goepferich
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 18, 2025
Control of biomedical nanoparticle distribution and drug release in vivo by complex particle design strategiesMelanie Bresinsky, Achim Goepferich
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 4, 2021
General sites of nanoparticle biodistribution as a novel opportunity for nanomedicineDaniel Fleischmann, Achim Goepferich
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2018
Nanoparticles Targeting Retinal and Choroidal Capillaries In VivoAlexandra Haunberger, Achim Goepferich
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 4, 2024
On the uncertainty of the correlation between nanoparticle avidity and biodistributionOliver Zimmer, Achim Goepferich
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2015
Nanoparticles for the treatment of ocular neovascularizationsRobert Hennig, Achim Goepferich
International Journal of Pharmaceutics|July 25, 2025
Dual cross-linked hydrogels as promising materials for drug deliveryCarsten Damm, Achim Goepferich
Biomaterials|October 3, 2006
Rational design of hydrogels for tissue engineering: impact of physical factors on cell behaviorFerdinand Brandl, Florian Sommer, Achim Goepferich
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 1, 2021
Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology - A new chance for causative therapy?Jonas Groner, Achim Goepferich, Miriam Breunig
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 16, 2014
Controlled release of therapeutic antibody formatsDaniel Schweizer, Tim Serno, Achim Goepferich
Pageof 9